FDA NDC Directory · JSON-LD · Markdown

KEBILIDI

NDC 52856-601 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameeladocagene exuparvovec-tneq
Labeler / ManufacturerPTC Therapeutics, Inc.
Marketing categoryBiologic License Application · App BLA125722
Dosage form / routeSUSPENSION · INTRACEREBRAL
Active ingredientsELADOCAGENE EXUPARVOVEC (560000000000 {GC}/mL)
Marketing started20241113
Package count1

External sources

Source: openFDA. Public-domain (CC0).